Nuzenio

Ca Lems

Ca Lems entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 4 latest news signals 1 publisher sources 100/100 entity strength

Latest news

VGCC Antibody Testing in Small Cell Lung Cancer: Assays, Interpretation, and the Seronegative Patient - OncLiveOncLive · Fri, 07 Aug 2026 20:36:55 GMTComprehensive Paraneoplastic Antibody Testing in Small Cell Lung Cancer: Beyond VGCC Alone - OncLiveOncLive · Fri, 07 Aug 2026 16:34:30 GMTThe CA LEMS Underdiagnosis Gap in Small Cell Lung Cancer: Prevalence, Attribution Bias, and the Neurology Referral Problem - OncLiveOncLive · Fri, 31 Jul 2026 12:14:29 GMTWhen to Act: Red Flags for CA LEMS in Small Cell Lung Cancer and the NCCN Testing Threshold - OncLiveOncLive · Fri, 31 Jul 2026 12:14:23 GMT

Timeline

Fri, 07 Aug 2026 20:36:55 GMTVGCC Antibody Testing in Small Cell Lung Cancer: Assays, Interpretation, and the Seronegative Patient - OncLive
Fri, 07 Aug 2026 16:34:30 GMTComprehensive Paraneoplastic Antibody Testing in Small Cell Lung Cancer: Beyond VGCC Alone - OncLive
Fri, 31 Jul 2026 12:14:29 GMTThe CA LEMS Underdiagnosis Gap in Small Cell Lung Cancer: Prevalence, Attribution Bias, and the Neurology Referral Problem - OncLive
Fri, 31 Jul 2026 12:14:23 GMTWhen to Act: Red Flags for CA LEMS in Small Cell Lung Cancer and the NCCN Testing Threshold - OncLive

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ca Lems.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.